Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Teriflunomide Transmission Can Occur in Female Partners of Men

Publish date:: April 16, 2019

Key clinical point: In a small sample of female sexual partners of patients on teriflunomide, 4 out of 10 had low detectable levels of the drug.

Major finding: Four women had detectable teriflunomide levels that averaged 0.045 mcg/mL (ranging from 0.022 to 0.077 mcg/mL).

Study details: An analysis of 10 couples that compared serum levels of teriflunomide in men with relapsing multiple sclerosis with those of their female partners.

Disclosures: The study was supported by a investigator-sponsored research grant from Sanofi-Genzyme. Dr. Guarnaccia reported that he has received speaking honoraria and educational grants from Sanofi-Genzyme, Biogen, Teva, Acorda Therapeutics, Bayer, EMD Serono, and Genentech.

Citation:

Guarnaccia JB et al. ACTRIMS Forum 2019, Poster 115.

This Week's Must Reads

Frequent soaks ease pediatric atopic dermatitis,

SZC passes extension test for hyperkalemia,

BCL11A-directed gene therapy advances in sickle cell disease,

Pimavanserin reduced dementia-related psychotic symptoms without affecting cognition,

Asthma exacerbation in pregnancy impacts moms, babies,

Must Reads in Neurology

Pimavanserin reduced dementia-related psychotic symptoms without affecting cognition,

High Infantile Spasm Risk Should Contraindicate Sodium Channel Blocker Antiepileptics,

Outcomes of epilepsy surgery at one year may be better among older patients,

Skip CTs for breakthrough seizures in chronic epilepsy,

Women with epilepsy less likely than controls to breastfeed,